Pharmacogenomics is a relatively new field that combines pharmacology and genomics to determine the drugs and doses that would work best for each individual. When genetic information is available, family physician Dr. Rose Kenny determines the best course of treatment for her patients through pharmacogenomics.
What does Pharmacogenomics Mean For Patients?
Drugs have traditionally been developed with the understanding that they have the same effect on each individual. But the study of the structure of DNA, or genomics, has paved the path for a more personalized approach to drug development and use. Genetic makeup determines how well a drug will work for each individual, as some drugs may be effective for one person, while not offering great results for another. With pharmacogenomics, doctors can use the genetic makeup of a patient to determine the drugs most likely to work best, eliminating the prescribing of unnecessary drugs.
How Prevalent is Pharmacogenomic Testing?
Routine pharmacogenomic testing is currently only used for several health problems. But the field is on the rise and will most likely lead to more individualized treatment options and better drug management in cancer, asthma, heart disease, depression and other more commonplace disorders.
Dr. Rose Kenny practices Family Medicine in Redmond, Oregon the Family Care Clinic, which she has owned and operated since 2002. At her practice, Dr. Kenny aims to combine clinical practices along with informatics to provide the best course of treatment for each patient. She is working towards her Masters in Biomedical Informatics at Oregon Health and Science University.